EN DE
Watch Aiforia Technologies Oyj for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Aiforia Technologies Oyj (AIFORIA) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Aiforia Technologies Oyj stock €0.69, price €0.88, that is 21.8% below the price, quality 30 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare FI

AT Aiforia Technologies Oyj logo Thin data Nov 10, 2026

Aiforia Technologies Oyj

AIFORIA · HE
Expensive, weak quality

Our calculation puts a fair price 22% below what the stock costs today.

Low debt
Expensive Growth (revenue 5y +33.0 %/yr in EUR)
Revenue last quarter 46% below a year ago.
Fair value €0.6881 · Overvalued
Quality 30/100
Negative free cash flow
Trails peers (1/8)
Narrow moat 13/100 · thin data
Thin data
Estimate
Watch Aiforia Technologies Oyj for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€5.53 €0.8470 Fair Value €0.6881 Dec 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

59‑month range €0.8470 – €5.53 · fair‑value band €0.5160 – €0.8601 · the €0.8800 price screens above the €0.6881 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Aiforia Technologies in your weekly email

Every Wednesday you see whether Aiforia Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally.

Show moreShow less

It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology workflow; and Aiforia Create, an agile solution to develop an AI model for image analysis application.

The company's products are used for the treatment of Parkinson's disease, organ transplantation, and liver and inflammatory bowel diseases. The company serves academic institutes and pharmaceutical companies through direct and sales partners.

Aiforia Technologies Oyj was incorporated in 2013 and is headquartered in Helsinki, Finland.

Stock analysis

Aiforia Technologies Oyj (AIFORIA) currently trades at €0.8800, while our estimate is €0.6881, 22% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: €0.5160 (bear) to €0.8601 (bull), the price of €0.8800 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Aiforia Technologies Oyj reported revenue of €3.5M in FY2025 versus €974K in FY2021, a compound +38.0%/yr. Reported net income was −€12.7M in FY2025.

Key figures

Market cap €32.9M Micro · P/S ratio 11.4 · EPS (TTM) €−0.4200 · Return on equity −77.5% · Return on assets (EBIT) −34.1% (5-year average) · Operating margin −1,012% · Revenue (TTM) €2.9M · Revenue growth (YoY) −46.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 13 out of 100 (low confidence).

What moves the price

The share trades about 67% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −35% fair-value upside, at −22%, AIFORIA screens cheaper than that median.

Fair Value

Bear €0.5160 Fair Value €0.6881 Bull €0.8601
Price €0.8800 · Downside -21.8%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 30/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 3
How much profit the company makes from its sales and capital
Quality Growth 59
Are margins and returns getting better?
Cashflow 2
Do the profits arrive as real cash?
Financial strength 67
Debt, balance sheet and risk of trouble
Investment 67
Does it invest with discipline instead of growing at any price?
Low Volatility 52
How calm the share price moves, does not count
Price momentum 9
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 1
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+23.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+33.0%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+33.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−310.0% (2020) → −316.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

AIFORIA screens overvalued: fair value 22% below the price. Compare with Veeva Systems Inc →

Compare Aiforia Technologies Oyj with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 141 stocks

Beats the industry median on 1/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 30 · Bottom 25%
Fair Value upside −21.8% · Below median
Profitability
Return on assets −43.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −46.0% · Bottom 25%
Balance sheet
Debt / equity 0.36× · Highest 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 1.93× · Cheaper than median
P/S (12 months) 11.37× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)4 · sector 13
FUTURE (revenue growth)0 · sector 45
PAST (return on equity)0 · sector 0
HEALTH (low debt)82 · sector 98
DIVIDEND (yield)0 · sector 46

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Doximity, Inc DOCS $32.42 $36.16 +12% vs AIFORIA
Veeva Systems Inc VEEV $305.55 $337.04 +10% vs AIFORIA
HealthEquity, Inc HQY $103.54 $112.32 +8% vs AIFORIA
Waystar Holding WAY $29.30 $29.10 −1% vs AIFORIA
Tempus AI, Inc TEM $80.54 $52.58 −35% vs AIFORIA
HeartFlow, Inc HTFL $55.80 $34.82 −38% vs AIFORIA
Hinge Health, Inc HNGE $123.23 $51.25 −58% vs AIFORIA
Pro Medicus Limited PME A$207.31 A$85.12 −59% vs AIFORIA
BrightSpring Health Services, Inc BTSG $72.49 $25.72 −65% vs AIFORIA
XtalPi Holdings 2228 HK$6.37 HK$1.53 −76% vs AIFORIA

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Aiforia Technologies Oyj: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Aiforia Technologies Oyj Fair Value". https://www.fairvalue-calculator.com/stock/AIFORIA

Frequently asked questions

Is Aiforia Technologies Oyj (AIFORIA) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is €0.6881 versus a price of €0.8800, about 22% lower (overvalued).
What is the fair value of AIFORIA?
Our estimate for Aiforia Technologies Oyj is €0.6881 (as of Nov 10, 2026), built from audited fundamentals. The current price: €0.8800.
What is the quality score of AIFORIA?
Aiforia Technologies Oyj has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Aiforia Technologies Oyj (AIFORIA)?
Our calculated price target is the estimate of €0.6881 (as of Nov 10, 2026). Cautious scenario €0.5160, optimistic scenario €0.8601. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Aiforia Technologies Oyj stock forecast for 2026?
Our estimate puts fair value at €0.6881, about 22% lower versus a price of €0.8800 (overvalued). Cautious scenario €0.5160, optimistic scenario €0.8601. The calculation is refreshed regularly with new filings.
What is the revenue of Aiforia Technologies Oyj (AIFORIA)?
Aiforia Technologies Oyj reported trailing-twelve-month revenue of about €2.9M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Aiforia Technologies Oyj (AIFORIA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Aiforia Technologies Oyj it is €0.6881 per share (as of Nov 10, 2026), against a price of €0.8800.
Is Aiforia Technologies Oyj stock overvalued or undervalued in 2026?
As of Nov 10, 2026, AIFORIA trades above its calculated fair value: price €0.8800, fair value €0.6881, a gap of about −22% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AIFORIA?
No. The price is what the market pays today (€0.8800); the fair value is what the company's own numbers justify (€0.6881). For Aiforia Technologies Oyj the two are €0.1919 per share apart. That gap is exactly why we show both numbers side by side.
How much is Aiforia Technologies Oyj worth?
The market values Aiforia Technologies Oyj at about €32.9M (market capitalisation, as of Nov 10, 2026). Per share that is €0.8800; our models calculate a fair value of €0.6881 per share.
What do the bullish and bearish scenarios say about AIFORIA?
Our models span a range for Aiforia Technologies Oyj: cautious scenario €0.5160, base €0.6881, optimistic €0.8601 per share (as of Nov 10, 2026, price €0.8800). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Aiforia Technologies Oyj (AIFORIA)?
Balance-sheet figures for Aiforia Technologies Oyj (as of Nov 10, 2026): return on equity −77.5%, debt of 0.36 per unit of equity. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is AIFORIA from its 52-week high?
Aiforia Technologies Oyj trades at €0.8800, about 67% below its 52-week high of €2.64 and 4% above the low of €0.8470 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of €0.6881 is for.
Which stocks are comparable to Aiforia Technologies Oyj?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Aiforia Technologies Oyj stock attractive at the current price?
The data as of Nov 10, 2026: price €0.8800, calculated fair value €0.6881 (−22%), Quality Score 30/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Aiforia Technologies Oyj itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Aiforia Technologies Oyj (AIFORIA)?
The closing price on Nov 10, 2026 was €0.8800. Our estimate is €0.6881, about 22% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Aiforia Technologies Oyj right now?
The price sits above even our optimistic bull case (€0.8601). The favourable scenario is already priced in. Weak quality (30/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Aiforia Technologies Oyj

How large is the market capitalisation of Aiforia Technologies Oyj (AIFORIA)?
The market capitalisation of Aiforia Technologies Oyj is €32.9M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Aiforia Technologies Oyj (AIFORIA)?
The price-to-sales ratio of Aiforia Technologies Oyj is 11.4 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Aiforia Technologies Oyj (AIFORIA)?
Earnings per share at Aiforia Technologies Oyj are €−0.4200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Aiforia Technologies Oyj (AIFORIA)?
The return on equity (ROE) of Aiforia Technologies Oyj is −77.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Aiforia Technologies Oyj (AIFORIA)?
On an EBIT basis the return on assets of Aiforia Technologies Oyj is −34.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Aiforia Technologies Oyj (AIFORIA)?
The operating margin of Aiforia Technologies Oyj is −1,012% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Aiforia Technologies Oyj (AIFORIA)?
Revenue at Aiforia Technologies Oyj is growing −46.0% versus a year earlier (3y avg +30.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Aiforia Technologies Oyj (AIFORIA) generate?
The free cash flow of Aiforia Technologies Oyj is −€14.2M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Aiforia Technologies Oyj (AIFORIA) carry?
The net debt of Aiforia Technologies Oyj is €1.3M (fiscal year 2020). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Aiforia Technologies Oyj in the live analysis

One click puts Aiforia Technologies Oyj on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.